Verastem Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 10 of 10 Posts
Where Is VSTM Headed?
Article By: Zion Miller Tuesday, January 22, 2019 11:17 PM EDT
With the recent bashing of the market as a whole and slaughter of small caps, VSTM continues to touch what some claim to be unfathomable levels.
In this article: VSTM Also: GILD, BMY, JNJ, MRK, NVS, RHHBY
Read
Verastem, De Risked?
Article By: Zion Miller Monday, December 31, 2018 4:11 PM EDT
VSTM has been pushed down for several reasons and was further damaged with the recent unfortunate bearish markets.
In this article: VSTM
Read
Week In Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer
Article By: ChinaBio® Today Saturday, September 29, 2018 4:11 PM EDT
ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.
In this article: A, VSTM, NVS, CBMG, TTPH
Read
3 ‘Strong Buy’ Stocks With Big Catalysts Ahead
Article By: TipRanks Wednesday, March 14, 2018 2:21 PM EDT
Which are three of the market’s hottest stocks right now?
In this article: VSTM, AQXP, SBBP
Read
VSTM Verastem Inc – Bullish Break
Article By: Elliottwave Forecast Wednesday, September 13, 2017 6:00 AM EDT
VSTM Verastem Inc has created a bullish break in the weekly time frame after the announcement of Positive Top-Line Data For Leukemia Treatment
In this article: VSTM
Read
Verastem Creates New 52 Weeks High
Article By: KKD Healthcare Analytics Tuesday, March 28, 2017 1:05 PM EDT
Verastem stock has shown strong performance as it grew over 44 percent in the past 12 months.
In this article: VSTM
Read
Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update
Article By: The Life Sciences Report Wednesday, March 9, 2016 5:47 PM EDT
Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China.
In this article: SGYP, CRMD, ORMP, SRNE, ARRY, PTIE, AGEN, GALE, PPHM, EVOK, ADMA, AKBA, KPTI, VSTM, AST, RXDX, AGTC, WVE, FATE, FLKS, PIRS, ABEO
Read
The 2016 Small-Cap Biotech Watchlist Debuts At The Biotech Showcase
Article By: The Life Sciences Report Wednesday, January 27, 2016 6:16 PM EDT
This may prove a challenging year for small-cap biotechs, but the five analysts who selected companies for inclusion on The Life Sciences Report's 2016 Small-Cap Biotech Watchlist believe these companies have a good producing value for investors.
In this article: AZN, NVO, SGYP, SNY, CRMD, ORMP, CMXHY, SRNE, ALNY, ARRY, INCY, IRWD, PTIE, REGN, VRTX, AGEN, GALE, GRFS, PPHM, EVOK, ADMA, AKBA, VSTM, AST, RXDX, AGTC, NK, WVE, FATE, FLKS
Read
Is There Value In Verastem?
Article By: IPO Candy Friday, October 9, 2015 9:32 AM EDT
The recent news for Verastem (Nasdaq:VSTM) has been terrible. Today they announced a layoff of 50% of their workforce which will get the company down to 20 people and save $4.9M a year in operating costs.
In this article: VSTM
Read
3 Stocks Where Insider Buying Activity Is Exploding: Verastem Inc, Kennametal Inc., And More
Article By: Insider Monkey Saturday, February 7, 2015 1:13 PM EDT
While our market beating small-cap strategy forms the basis for our investment platform, there’s one other proven, return-generating commodity that we also track, and that is insider trading activity.
In this article: KMTG, SFNC, VSTM
Read
1 to 10 of 10 Posts